Is 2-hydroxypropyl-β-cyclodextrin a suitable carrier for central administration of Δ9-tetrahydrocannabinol? Preclinical evidence

AGABIO, ROBERTA;SANNA, FABRIZIO;MONDUZZI, MAURA;NAIRI, VALENTINA;CUGIA, FRANCESCA;MELIS, MARIA ROSARIA
2017

Abstract

D9-Tetrahydrocannabinol (THC) is a hydrophobic compound that has a potent antinociceptive effect in animals after intrathecal (IT) or intracerebroventricular (ICV) administration. The lack of a suitable solvent precludes its IT administration in humans. 2-Hydroxypropyl-b-cyclodextrin (HPbCD) iincreases the water solubility of hydrophobic drugs and is approved for IT administration in humans. To investigate whether HPbCD might be a suitable carrier for ICV administration of THC in rats, two formulations containing THC complexed with HPbCD (30 and 135 lg of THC per animal) and vehicle were administered to Wistar rats. The antinociceptive effect (using the tail flick test), locomotor activity, and body temperature were evaluated. ICV injection of 135 lg of THC/HPbCD complex increased tail flick latency, reduced locomotor activity, and had a dual effect on body temperature. The 30 lg THC/HPbCD 41 formulation only produced a hyperthermic effect. All animals appeared healthy, with no difference between the groups. These results were similar to those obtained in other preclinical studies in which THC was administered centrally using solvents that are unsuitable for IT administration in humans because of their toxicity. Our findings suggest that HPbCD may be a useful carrier for IT administration of THC in humans.
eng
78
8
411
419
9
Esperti anonimi
internazionale
Scientifica
Tetrahydrocannabinol (THC); 2-hydroxypropyl-β-cyclodextrin (HPβCD); intracerebroventricular administration (ICV); Pain; Analgesia; Rat
no
Agabio, Roberta; Sanna, Fabrizio; Lobina, C; Monduzzi, Maura; Nairi, Valentina; Cugia, Francesca; Mameli, S; Pisanu, Gm; Gessa, Gl; Melis, MARIA ROSARIA
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
10
reserved
File in questo prodotto:
File Dimensione Formato  
Copia per IRIS.pdf

non disponibili

Descrizione: Versione pre-referaggio
Tipologia: versione pre-print
Dimensione 510.62 kB
Formato Adobe PDF
510.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie